VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811 Recall
VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811
FDA recall Class II
Ongoing
FDA lists this Class II recall for VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-3231-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jul 24, 2026
- FDA report date
- Sep 30, 2026
- Quantity in commerce
- 97680 units
- Distribution
- See key details
- FDA cause
- Packaging process control
What is being recalled?
VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811
Affected model & UDI checker
Search the exact identifiers published for Z-3231-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811 | Check source notice | 03573026637712 |
FDA code information
UDI-DI 03573026637712; Lot Number 1333393504
Why was this product recalled?
The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False resistant results may lead to the use of less effective antibiotic treatments or the association of multiple antibiotics having negative side effects, which could potentially impact patient s health.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did BIOMERIEUX, Inc. take?
An URGENT FIELD SAFETY NOTICE notification letter was sent to customers beginning 7/24/26. Required actions Dispose of any remaining inventory VITEK 2 AST-N461 TEST KIT (Ref 424811, Lot 1333393504) that were manufactured with Poucher 8 with timestamps from 10:06:00 to 11:11:59, as identified by product labeling. Inspect each pouch in inventory and dispose of cards with "P8" and timestamps between 10:06:00 to 11:11:59 on the label. Alternatively, dispose of all cards from Lot 1333393504 remaining in inventory. In accordance with your facility s policies, you may consider performing a retrospective review of clinically significant resistant results. Among tests previously performed, identify any possible false resistant results that may have occurred, analyze the related risks, and determine appropriate actions, if applicable. Please ensure that this information is communicated to all relevant personnel within your laboratory, retain a copy in your records, and forward this information to all parties that may use this product, including those to whom you may have transferred the product. Please complete the Acknowledgement Form in Attachment A and return it to your local bioMrieux representative to confirm receipt of this notice. It is important that you return the acknowledgement form to bioMrieux even if you determine that this product correction notice does not impact your facility. As a reminder, please visit the Resource Center to confirm if a reference package insert is associated with a Field Corrective Action or Field Safety Corrective Action. https://resourcecenter.biomerieux.com/ If you require additional assistance or have any questions, please contact your local bioMrieux Customer Service representative.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-3231-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology